PTON Peloton Interactive stock climbs 465 percent despite missing Q1 2026 earnings per share estimates Moderna MRNA Stock Buy or Sell Q4 2025 Profit Surprises FGBI First stock falls 296 after posting 95 Q4 2025 EPS miss against analyst consensus estimates AbbVie Inc ABBV Submits SKYRIZI Subcutaneous Crohns Regimen to FDA But NearTerm Upside Remains Capped By Competitive Risks How does Exelixis EXEL PE compare to sector Slight Gain 20260427